Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
25%
Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Recruiting2
Completed2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (25.0%)
N/A3 (75.0%)

Trials by Status

recruiting250%
completed250%

Recent Activity

2 active trials
Showing 4 of 4
recruitingphase_2

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

NCT07104630
recruitingnot_applicable

Effectiveness of Decision Support for Cardiovascular Risk Management in People With Cardiovascular Disease

NCT06871514
completednot_applicable

Pilot of IMPACT Intervention at the University of New Mexico

NCT04166994
completednot_applicable

Combined Social Worker and Pharmacist Transitional Care Program

NCT01503554

Clinical Trials (4)

Showing 4 of 4 trials
NCT07104630Phase 2

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors

Recruiting
NCT06871514Not Applicable

Effectiveness of Decision Support for Cardiovascular Risk Management in People With Cardiovascular Disease

Recruiting
NCT04166994Not Applicable

Pilot of IMPACT Intervention at the University of New Mexico

Completed
NCT01503554Not Applicable

Combined Social Worker and Pharmacist Transitional Care Program

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4